Clinical trials start with early discovery and ongoing research. After approval by the FDA, the research goes through the following phases. Patient participants are essential to clinical trials. Ask ...

BDC-3042 is a proprietary agonist antibody that targets dectin-2, an immune-activating receptor expressed by tumor-associated macrophages (TAMs). This single-agent, dose-escalation Phase 1 clinical ...

Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...

Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced the successful completion of the Phase III clinical study ...

Ulcerative colitis (UC) is one of the most severe chronic diseases, causing relentless gastrointestinal pain and ...